
Clinical Research
Beyond the Abstract: What the Landmark Lancet Psychiatry Cannabinoid Review Shows
A major new systematic review has concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental

A major new systematic review has concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental

First published on Cannabis Health Medical cannabis patients made history in London with a first-of-its-kind, patient-led education event focused on

Sorting Evidence from Anecdote As global cannabis research accelerates, the number of published studies has never been higher, but not

Curaleaf Laboratories has been confirmed as headline sponsor of the inaugural Cannabis Health Symposium, taking place on 25 November 2025
Each winner receives £2,000 in data and media · Closes 23:59 BST, 13 May 2026